RADIATION THERAPY ONCOLOGY GROUP
RTOG 0522
A RANDOMIZED PHASE III TRIAL OF CONCURRENT ACCELERATED RADIATION AND CISPLATIN VERSUS CONCURRENT ACCELERATED RADIATION, CISPLATIN, AND CETUXIMAB (C225) [FOLLOWED BY SURGERY FOR SELECTED PATIENTS] FOR STAGE III AND IV HEAD AND NECK CARCINOMAS
RTOG 0522
A RANDOMIZED PHASE III TRIAL OF CONCURRENT ACCELERATED RADIATION AND CISPLATIN VERSUS CONCURRENT ACCELERATED RADIATION, CISPLATIN, AND CETUXIMAB (C225) [FOLLOWED BY SURGERY FOR SELECTED PATIENTS] FOR STAGE III AND IV HEAD AND NECK CARCINOMAS
Please note: RTOG 0522 is closed to accrual as of March 3, 2009.
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I is required for this protocol.
- Dry Run Guidelines (5/19/06)
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Checklist
- ATC Compliant Treatment Planning Systems
- QA Scoring Criteria
- Structure Names
- Neck Node Atlas
- Protocol Text (http://www.rtog.org)
Back to protocols
